Business Description
Concord Biotech Ltd
ISIN : INE338H01029
Compare
Compare
Traded in other countries / regions
543960.India IPO Date
2023-08-18Description
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 92.97 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 318.84 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 70.89 | |||||
| Beneish M-Score | -2.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.2 | |||||
| 3-Year EBITDA Growth Rate | 11.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9 | |||||
| 3-Year Book Growth Rate | 15.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 28.98 | |||||
| Future 3-5Y Total Revenue Growth Rate | 22.78 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.33 | |||||
| 9-Day RSI | 77.37 | |||||
| 14-Day RSI | 69.77 | |||||
| 6-1 Month Momentum % | 25.41 | |||||
| 12-1 Month Momentum % | 41.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | |||||
| Quick Ratio | 4.83 | |||||
| Cash Ratio | 2.25 | |||||
| Days Inventory | 302.31 | |||||
| Days Sales Outstanding | 109.6 | |||||
| Days Payable | 112.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.41 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| Forward Dividend Yield % | 0.41 | |||||
| 5-Year Yield-on-Cost % | 0.41 | |||||
| Shareholder Yield % | 0.56 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.42 | |||||
| Operating Margin % | 38.69 | |||||
| Net Margin % | 30.74 | |||||
| FCF Margin % | 16.85 | |||||
| ROE % | 22 | |||||
| ROA % | 19.61 | |||||
| ROIC % | 23.73 | |||||
| ROC (Joel Greenblatt) % | 36.3 | |||||
| ROCE % | 29.11 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 64.98 | |||||
| Forward PE Ratio | 53.1 | |||||
| PE Ratio without NRI | 64.98 | |||||
| Price-to-Owner-Earnings | 103.87 | |||||
| PS Ratio | 19.96 | |||||
| PB Ratio | 13.39 | |||||
| Price-to-Tangible-Book | 13.98 | |||||
| Price-to-Free-Cash-Flow | 118.52 | |||||
| Price-to-Operating-Cash-Flow | 80.25 | |||||
| EV-to-EBIT | 49.49 | |||||
| EV-to-EBITDA | 44.12 | |||||
| EV-to-Revenue | 20.52 | |||||
| EV-to-FCF | 109.4 | |||||
| Price-to-Graham-Number | 6.49 | |||||
| Price-to-Net-Current-Asset-Value | 29.22 | |||||
| Price-to-Net-Cash | 153.95 | |||||
| Earnings Yield (Greenblatt) % | 2.01 | |||||
| FCF Yield % | 0.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Concord Biotech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 10,668.669 | ||
| EPS (TTM) (₹) | 31.34 | ||
| Beta | 0 | ||
| Volatility % | 33.04 | ||
| 14-Day RSI | 69.77 | ||
| 14-Day ATR (₹) | 86.779347 | ||
| 20-Day SMA (₹) | 1925.5625 | ||
| 12-1 Month Momentum % | 41.45 | ||
| 52-Week Range (₹) | 1277.75 - 2658 | ||
| Shares Outstanding (Mil) | 104.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Concord Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Concord Biotech Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Concord Biotech Ltd Frequently Asked Questions
What is Concord Biotech Ltd(BOM:543960)'s stock price today?
The current price of BOM:543960 is ₹2124.45. The 52 week high of BOM:543960 is ₹2658.00 and 52 week low is ₹1277.75.
When is next earnings date of Concord Biotech Ltd(BOM:543960)?
The next earnings date of Concord Biotech Ltd(BOM:543960) is .
Does Concord Biotech Ltd(BOM:543960) pay dividends? If so, how much?
The Dividend Yield %  of Concord Biotech Ltd(BOM:543960) is 0.41% (As of Today), Highest Dividend Payout Ratio of Concord Biotech Ltd(BOM:543960) was 0.28. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Concord Biotech Ltd(BOM:543960) is 0.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers